Vivo Opportunity LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Purchase | 2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 2,482,727 4.500% | 801,528 (+47.68%) | Filing |
| 2023-02-13 5:40 pm Purchase | 2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 1,681,199 6.800% | 681,199 (+68.12%) | Filing |
| 2022-09-08 4:00 pm Purchase | 2022-08-31 | 13G | Astria Therapeutics, Inc. ATXS | Vivo Opportunity LLC | 1,000,000 7.100% | 1,000,000 (New Position) | Filing |